Additional treatment not effective to treat pancreatic cancer
Median overall survival was 11.9 months in patients receiving gemcitabine plus erlotinib.
Median overall survival was 11.9 months in patients receiving gemcitabine plus erlotinib.
Direct-acting antivirals pose challenges in patients with hepatitis C and prior hepatocellular carcinoma
The rates of many cancers increase in in HIV positive individuals.
The combination of tomosynthesis and digital mammography screening may benefit women with heterogeneously dense breasts.
The new vaccine protects against 9 types of HPV and 5 cancer-causing strains.
50% of women studied met the American Cancer Society requirements for early mammography screening.
The American Society of Clinical Oncology has released its recommendations to help improve rates of HPV vaccination worldwide.
A low-dose aspirin regimen was associated with a 3% lower risk of cancer overall.
Contaminated water leads to high rates of birth defects, thyroid cancer, and spontaneous abortions.
Families of patients who receive aggressive end-of-life medical care do not perceive the care as high-quality.